Compare DAR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAR | RGEN |
|---|---|---|
| Founded | 1882 | 1981 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.0B |
| IPO Year | 2002 | 1995 |
| Metric | DAR | RGEN |
|---|---|---|
| Price | $65.23 | $177.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $65.82 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 2.5M | 914.0K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 3.24 | 0.24 |
| Revenue | ★ $6,135,877,000.00 | $141,236,000.00 |
| Revenue This Year | $7.78 | $14.30 |
| Revenue Next Year | $3.37 | $14.52 |
| P/E Ratio | ★ $20.52 | $742.46 |
| Revenue Growth | 7.36 | ★ 35.10 |
| 52 Week Low | $29.15 | $100.99 |
| 52 Week High | $69.98 | $188.73 |
| Indicator | DAR | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 61.30 |
| Support Level | $57.88 | $158.15 |
| Resistance Level | $69.31 | $188.73 |
| Average True Range (ATR) | 2.38 | 6.73 |
| MACD | -0.21 | -0.25 |
| Stochastic Oscillator | 51.71 | 79.98 |
Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.